Effectiveness and cost-effectiveness of a web-based cardiac rehabilitation programme for people with chronic stable angina: protocol for the ACTIVATE (Angina Controlled Trial Investigating the Value of the 'Activate your heart Therapeutic E-intervention) randomised controlled trial

Williams,N. H.,Collins,B.,Comerford,T. J.,Dodd,S.,Fisher,M.,Hardwick,B.,Hennessy,S.,Jolly,K.,Jones,I.,Lane,D.,Lip,G. Y. H.,Morgan,E.,Ralph,P.,Thijssen,D.,Singh,S. J.
DOI: https://doi.org/10.1136/bmjopen-2024-084509
IF: 3.006
2024-03-27
BMJ Open
Abstract:Introduction Chronic stable angina is common and disabling. Cardiac rehabilitation is routinely offered to people following myocardial infarction or revascularisation procedures and has the potential to help people with chronic stable angina. However, there is insufficient evidence of effectiveness and cost-effectiveness for its routine use in this patient group. The objectives of this study are to compare the effectiveness and cost-effectiveness of the 'Activate Your Heart' cardiac rehabilitation programme for people with chronic stable angina compared with usual care. Methods and analysis ACTIVATE is a multicentre, parallel-group, two-arm, superiority, pragmatic randomised controlled trial, with recruitment from primary and secondary care centres in England and Wales and a target sample size of 518 (1:1 allocation; allocation sequence by minimisation programme with built-in random element). The study uses secure web-based allocation concealment. The two treatments will be optimal usual care (control) and optimal usual care plus the 'Activate Your Heart' web-based cardiac rehabilitation programme (intervention). Outcome assessment and statistical analysis will be performed blinded; participants will be unblinded. Outcomes will be measured at baseline and at 6 and 12 months' follow-up. Primary outcome will be the UK version of Seattle Angina Questionnaire (SAQ-UK), physical limitations domain at 12 months' follow-up. Secondary outcomes will be the remaining two domains of SAQ-UK, dyspnoea, anxiety and depression, health utility, self-efficacy, physical activity and the incremental shuttle walk test. All safety events will be recorded, and serious adverse events assessed to determine whether they are related to the intervention and expected. Concurrent economic evaluation will be cost–utility analysis from health service perspective. An embedded process evaluation will determine the mechanisms and processes that explain the implementation and impacts of the cardiac rehabilitation programme. Ethics and dissemination North of Scotland National Health Service Research Ethics Committee approval, reference 21/NS/0115. Participants will provide written informed consent. Results will be disseminated by peer-reviewed publication. Trial registration number ISRCTN10054455.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the effectiveness and cost - effectiveness of a web - based cardiac rehabilitation program (“Activate Your Heart”) for patients with chronic stable angina. Specifically, the main objectives of the study are: 1. **Effectiveness evaluation**: Compare the impact of the web - based cardiac rehabilitation program and routine care on the health status (especially the quality of life related to angina) of patients with chronic stable angina, mainly evaluated by the Seattle Angina Questionnaire (SAQ - UK) physical limitation domain score at the 12 - month follow - up. 2. **Cost - effectiveness evaluation**: Conduct an economic evaluation from the perspective of health services to determine whether the cardiac rehabilitation program is cost - effective. 3. **Implementation mechanism and process evaluation**: Explore the implementation mechanism and impact process of the cardiac rehabilitation program in the intervention group, as well as the situation in the routine care group. 4. **Barriers and facilitators to participation and completion**: Identify the barriers and facilitators to participation and completion of the cardiac rehabilitation program, with a focus on equity issues. ### Research background Chronic stable angina is a common and disabling disease. Although cardiac rehabilitation has been widely adopted in patients after myocardial infarction or revascularization, there is insufficient evidence of its effectiveness and cost - effectiveness in patients with chronic stable angina. Currently, the National Institute for Health and Care Excellence (NICE) in the UK does not support the routine provision of cardiac rehabilitation in this patient group until there is stronger evidence to support its effectiveness and cost - effectiveness. ### Research design - **Trial design**: Multicenter, parallel - group, two - arm, superiority randomized controlled trial (RCT), stratified by gender and recruitment site, with a target sample size of 518 (1:1 allocation). - **Interventions**: The intervention group received routine care plus the “Activate Your Heart” online cardiac rehabilitation program, and the control group received only routine care. - **Primary outcome**: The SAQ - UK physical limitation domain score at the 12 - month follow - up. - **Secondary outcomes**: Including the other two domains of SAQ - UK, dyspnea, anxiety and depression, health utility, self - efficacy, physical activity and incremental shuttle walk test, etc. ### Methods and analysis - **Baseline characteristics**: Use descriptive statistical methods to summarize the demographic and clinical characteristics of each randomized group. - **Effectiveness analysis**: Report the differences between groups at each time point after adjusting for baseline scores and stratification factors using analysis of covariance (ANCOVA). - **Missing data handling**: Use regression models to predict missing data and perform sensitivity analysis to examine the differences in results between different randomized groups. ### Conclusion This study aims to fill the evidence gap in the effectiveness and cost - effectiveness of cardiac rehabilitation in patients with chronic stable angina and provide a scientific basis for clinical decision - making.